Clinical Trial Update: D-serine for the Schizophrenia Prodrome [Phase 2]

View source ↗

Summary

Phase 2 trial update showing results for D-serine in the schizophrenia prodrome; the study completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Nathan Kline Institute for Psychiatric Research | Conditions: Schizophrenia Prodrome | Phase 2 | Status: COMPLETED | Results posted: 2017-02-08